| Application no. and date | 14721647.7 (espacenet) (Federated) (European Patent Register), 20140314 | | Patent/reg. no. and date | DK/EP 2972360, 20180307 | | Publication date | 20160120 | | Priority no. and date | US 201361789375 P, 20130315 | | EP pub. no. and date |
EP 2972360 20160120 | | Effective date | | | Applicant/owner | Translate Bio, Inc., 200 Sidney Street,
Suite 310
Cambridge, MA 02139, US | | Applicant ref. no. | P64639DK01 | | Inventor | GUILD, Braydon Charles, 109 Riverdale Road
Concord
Massachusetts 01742, US,
HEARTLEIN, Michael, c/o Shire Human Genetic Therapies Inc.
300 Shire Way
Lexington
Massachusetts 02421, US,
DEROSA, Frank, c/o Shire Human Genetic Therapies Inc.
300 Shire Way
Lexington
Massachusetts 02421, US,
SMITH, Lianne, c/o Shire Human Genetic Therapies Inc.
300 Shire Way
Lexington
Massachusetts 02421, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | G01N 33/543 (2006.01) | | Title | SYNERGISTISK FORBEDRING AF LEVERINGEN AF NUKLEINSYRER VIA BLANDEDE FORMULERINGER | | Int. application no. | US2014028498 | | Int. publication no. | WO2014144196 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
